Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head

Summary

The purpose of this study is to determine if Ixmyelocel-T grafting with demineralized bone matrix bound in autologous plasma after core decompression surgery is superior to core decompression with demineralized bone matrix bound in autologous plasma in preventing progression of osteonecrosis to a more severe disease stage (Stage II to III or higher) from the time of surgery until 24 months later, in patients with University of Pennsylvania (UPenn) Stage IIB or C disease at diagnosis.

Timeline

Start

2007-09

Primary completion

2010-09

Completion

2010-12

Drugs

Indications